Join a Legacy of Innovation 125 Years and Counting!
Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical therapies to improve standards of care and address diversified, unmet medical needs of people globally by leveraging our world-class science and technology. With more than 125 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 18,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for cardiovascular diseases, under the Group’s 2025 Vision to become a “Global Pharma Innovator with Competitive Advantage in Oncology,” Daiichi Sankyo is primarily focused on providing novel therapies in oncology, as well as other research areas centered around rare diseases and immune disorders.
Summary
The Manager, Sustainability will be a member of the company's Compliance Department and will report to the US Sustainability leader and will 1) manage the US Environmental Social Governance (ESG) Sustainability initiatives and partner with colleagues in Japan and at US affiliates to accomplish the company's ESG goals and 2) support various components of the company's corporate sustainability programs, including external disclosure reporting and ESG auditing.
Responsibilities
- Manage and Support US Environmental, Social, Governance (ESG) Sustainability Initiatives and greenhouse gas (GHG) and other ESG Metrics reporting and accounting. Working with management from each US affiliate promote awareness and support the global Corporate Conduct Charter. Create and maintain a responsibility matrix for purposes of tracking, collecting and reporting ESG data. Collaborate with appropriate departments to communicate the organization’s environmental sustainability strategy, initiatives, progress, and achievements with colleagues, clients, stakeholders, and vendors. Track key performance indicators (KPIs) to identify progress on important sustainability metrics. Support the development of an environmental sustainability commitment statement, charter, and strategic plan to incorporate environmental sustainability into the organization’s current framework.
- Propose and promote sustainability initiatives supporting due diligence efforts under the company's human rights policy, and support data collection for global health management and access to healthcare programs. Develop e-learning and other educational programs to promote sustainability initiatives.
- Assist leader in serving as liaison to Sustainability Department in Tokyo and within US affiliates including arranging and attending global sustainability meetings, developing quarterly reports, supporting the global sustainability websites and value report, arranging and supporting Environmental Health and Safety (EHS) audit requests.
Qualifications: Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.
Education Qualifications (from an accredited college or university)
- Bachelor's Degree Engineering, Science or Sustainability related studies (preferred areas of study) required
Experience Qualifications
- 5+ years in ESG, Sustainability Management and GHG reporting and accounting required
- 2+ years in Carbon/GHG metrics quantification and verification techniques and tools (GHG Scope 1, 2, and 3 emissions) required
- 2+ years Sustainability/ESG disclosure under various common standards and frameworks (CSRD, GRI, TCFD, CDP, etc.) preferred
- In Pharmaceutical industry preferred
- Life-cycle assessment and Environmental Product Declaration development preferred
- Speaks Japanese preferred
Travel
Ability to travel up to 10%. May require travel to Japan or Europe or between affiliates in the US periodically
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.
What We Do
Daiichi Sankyo is dedicated to creating new modalities and innovative medicines by leveraging our world-class science and technology for our purpose “to contribute to the enrichment of quality of life around the world.” In addition to our current portfolio of medicines for cancer and cardiovascular disease, Daiichi Sankyo is primarily focused on developing novel therapies for people with cancer as well as other diseases with high unmet medical needs. With more than 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation to realize our 2030 Vision to become an “Innovative Global Healthcare Company Contributing to the Sustainable Development of Society.” For more information, please visit www.daiichisankyo.com.